Short steroid treatment for lung infection from PCP in HIV
Part of Immune system & allergy, Infections, Lungs & breathing clinical trials.
This study tests whether short-term steroid treatment helps adults with a specific lung infection (PCP) that happens with HIV/AIDS. It compares outcomes in people who start steroids soon after admission while also taking standard PCP antibiotics.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be over 18 years old
- Have lung test results at admission showing moderate or severe PCP
- Be taking the standard PCP antibiotic (trimethoprim/sulfamethoxazole) soon after admission at the study dosing
- Start steroid treatment within the first 48 hours after admission
- Have no long-term (chronic) lung disease and have an APACHE score under 20
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether a shorter or longer course of steroids works better for people recovering from severe Pneumocystis pneumonia (a lung infection). If you are 18 or older and have been on steroids for about 10 days but no longer need extra oxygen, you may be able to join.
This Phase 3 study tests whether low-dose trimethoprim-sulfamethoxazole (also called TMP-SMX) can treat Pneumocystis pneumonia (PCP) in people with weakened immune systems. It may help improve treatment while reducing side effects compared with standard dosing.
This trial tests different antibiotics for people with pneumocystis pneumonia who cannot take the standard treatment. It aims to find the best alternative therapy.
This trial tests whether adding corticosteroids helps non-HIV immunocompromised adults with severe Pneumocystis pneumonia in the ICU. If you meet the criteria, you may be randomly assigned to receive either steroids plus standard care or standard care alone.
This trial tests if giving steroids early, based on your immune system, can help treat severe pneumonia that needs ICU care. It aims to reduce inflammation and improve recovery.
This study tests whether giving steroids (a type of anti-inflammatory medicine) to adults hospitalized with severe respiratory infections can help them recover faster. If you have a serious lung infection and low oxygen levels, this trial may be an option for you.
Hear when a new Pneumocystis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.